| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $90.4M | -13.1% |
| SG&A Expense | $62.9M | -45.0% |
| Operating Income | -$153.3M | +51.3% |
| Pre-tax Income | -$144.7M | +52.1% |
| Income Tax | $46K | +111.7% |
| Net Income | -$144.7M | +52.0% |
| EPS (Basic) | -$1.53 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $226.7M | +192.9% |
| Short-term Investments | $90.3M | -8.9% |
| Accounts Receivable | $88K | -80.3% |
| Current Assets | $323.7M | +70.9% |
| Total Assets | $332.6M | +71.8% |
| Current Liabilities | $22.7M | -20.1% |
| Total Liabilities | $27.4M | -5.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$123.3M | +26.4% |
| Capital Expenditures | $138K | -12.1% |
| Investing Cash Flow | $14.0M | -81.4% |
| Financing Cash Flow | $257.0M | — |
| Free Cash Flow | -$123.5M | +26.4% |
| +65.5% |
| EPS (Diluted) | -$1.53 | +65.5% |
| Stockholders' Equity |
| $305.3M |
| +85.3% |